ArticleFrontiers in pharmacology2022

Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance.

Hongmei Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.